semaglutide chemist warehouse Ozempic about to hit shelves… but there's a catch New Zealand's Cheapest Online Pharmacy?

These medications slow gastric emptying, meaning food remains in the stomach longer before moving into the small intestine

Safety Comparison# Semaglutide# Well-characterized safety profile across thousands of patients: GI adverse events: 50-70% (mostly mild-moderate, dose-escalation related) Discontinuation due to AEs: ~7% (STEP 1) Boxed warning: Thyroid C-cell tumors (rodent data) Post-marketing signals: Pancreatitis, gallbladder events, ileus (rare) 8+ years of post-marketing surveillance Zovaglutide# Phase 2 safety data (303 patients, 24 weeks): GI adverse events: Present but low severity Discontinuation due to GI AEs: 1.3% (notably low for GLP-1 class) Monthly dosing showed fewer GI events than biweekly dosing No long-term safety data available No post-marketing experience The 1.3% GI-related discontinuation rate is notably lower than typical GLP-1 agonists (5-10%)

Prior authorization processes can delay treatment by 48 weeks while insurers review medical necessity

The use of NNT as a tool to communicate value to stakeholders has advantages and disadvantages

chest pain or stroke signs require an immediate 999 call